Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01333800Phase 4Completed
Phase 4, randomised, single-blind trial of ciclesonide in asthma (2 arms), sponsored by Grünenthal GmbH. Primary endpoint: Number of patients free of asthmatic crisis at 6 months. Started Jul 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01333800.